Evidence map›Paper›PMID 37820298›Full record

ArticleAnalytical chemistry2023

Mass-Activated Droplet Sorting for the Selection of Lysine-Producing

Emory M Payne, Bridget E Murray, Laura I Penabad, Eric Abbate, Robert T Kennedy

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Machine vision-enabled ODThe Analyst · 2026
    Article
  2. Article
  3. Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Innovative Advances in Droplet Microfluidics.Research (Washington, D.C.) · 2025
    Review
  8. Article
  9. OptimizingFrontiers in microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emory M PayneDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48103, United States.ORCID 0000-0002-5956-8392
Bridget E MurrayDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48103, United States.ORCID 0000-0001-9865-9046
Laura I PenabadDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48103, United States.
Eric AbbateApplications Development, Inscripta Inc., Pleasanton, California 94588, United States.
Robert T KennedyDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48103, United States.ORCID 0000-0003-2447-7471
University of Michigan · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Microfluidic Systems to Enable Enzyme Engineering for Chemical SynthesisR01GM150948 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERT T KENNEDY · 2023 to 2026
$1.3M
NIDDK NIH HHS P30 DK020572NIGMS NIH HHS R01 GM150948NIGMS NIH HHS R01-GM150948
6 · The paper itself

Abstract

Synthetic biology relies on engineering cells to have desirable properties, such as the production of select chemicals. A bottleneck in engineering methods is often the need to screen and sort variant libraries for potential activity. Droplet microfluidics is a method for high-throughput sample preparation and analysis which has the potential to improve the engineering of cells, but a limitation has been the reliance on fluorescent analysis. Here, we show the ability to select cell variants grown in 20 nL droplets at 0.5 samples/s using mass-activated droplet sorting (MADS), a method for selecting droplets based on the signal intensity measured by electrospray ionization mass spectrometry (ESI-MS).

Indexed as

Escherichia coliLysineCell EngineeringCell MovementColoring AgentsColoring AgentsLysine

Identifiers

PMID37820298
PMCPMC11025463
OpenAlexW4387522247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.